期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Clinical Effect of Zishenwan on Elderly Patients with Prediabetes Based on the Method of Sweet-Bitter Therapeutic 被引量:3
1
作者 Chunbo JIANG erli lu Guoqiang LIANG 《Medicinal Plant》 CAS 2022年第1期63-66,共4页
[Objectives]To study the clinical effect of Zishenwan on elderly patients with prediabetes based on the method of Sweet-Bitter Therapeutic.[Methods]Total 64 elderly patients with prediabetes in Suzhou TCM Hospital Aff... [Objectives]To study the clinical effect of Zishenwan on elderly patients with prediabetes based on the method of Sweet-Bitter Therapeutic.[Methods]Total 64 elderly patients with prediabetes in Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine from April,2020 to July,2021 were randomly divided into control group(32 cases)and Zishenwan group(32 cases).The control group received basic treatment(diet control and regular luck exercise),while the Zishenwan group was treated with Zishenwan on the basic treatment.[Results]The results of intragroup comparisons after treatment show that both of the groups improved plasma glucose,insulin,plasma lipid metabolism and other related indexes.The results of inter-group comparisons were as follows.(i)The FPG and 2hPG of the Zishenwan group were significantly lower than the control group(P<0.05).(ii)The FINS and HOMA-IR of the Zishenwan group were significantly lower than the control group(P<0.05).(iii)The LDL-C of the Zishenwan group were significantly lower than the control group(P<0.05).(iv)The ADP,hs-CRP,and GLP-1 of the Zishenwan group were significantly improved compared to those of the control group(P<0.05).Although there was no significant difference in other indicators,the improvement trend is better than that of the control group.[Conclusions]Zishenwan can further improve plasma glucose level of the elderly patients with prediabetes on the basis of basic treatment,and to a certain extent,reduce the plasma glucose to normal,which is beneficial to the benign outcome of the elderly patients with prediabetes.In addition,it can improve insulin secretion and reduce insulin resistance,which provides a basis for the disease control of elderly patients with prediabetes.It can also improve the lipid metabolism of elderly patients with prediabetes,and the effect on LDL-C is significant.It is speculated that its mechanism may be closely related to the changes of ADP,hs-CRP and GLP-1 in the body of elderly patients with prediabetes. 展开更多
关键词 Sweet-Bitter Therapeutic Zishenwan Elderly patients with prediabetes Clinical research
下载PDF
Effects of Chinese Patent Drug Zishen Pills in Treatment of Elderly Patients with Impaired Glucose Tolerance(IGT)
2
作者 Yejun WENG Guoqiang LIANG erli lu 《Medicinal Plant》 CAS 2022年第6期40-43,共4页
[Objectives]To evaluate the efficacy of Zishen Pills(ZSP),a Chinese patent drug,in the treatment of elderly patients with impaired glucose tolerance(IGT)and its effects on the prevention of diabetes mellitus(DM).[Meth... [Objectives]To evaluate the efficacy of Zishen Pills(ZSP),a Chinese patent drug,in the treatment of elderly patients with impaired glucose tolerance(IGT)and its effects on the prevention of diabetes mellitus(DM).[Methods]Thirty-five IGT patients were randomized to receive 10 g of ZSP three times daily(ZSP group,n=24)or no drug intervention(control group,n=11)for 12 weeks.Oral glucose tolerance test,glycated hemoglobin A1c(HbA1c),body mass index,blood lipids levels,fasting insulin,and insulin resistance calculated using homeostatic model assessment(HOMA-IR)of all the patients were observed and compared before and after the treatment.[Results]Thirty participants completed the trial(20 in ZSP group and 10 in the control group).There were statistically significant decreases in plasma triglycerides(TG),fasting blood-glucose(FBG),2-h plasma glucose(2-h PG),HbA1c,and HOMA-IR in ZSP group compared with the control group after 12 weeks of treatment(P<0.05 or P<0.01).After 12 weeks of treatment,2(20.0%)patients returned to normal blood glucose,and 2(20.0%)patients turned into DM in control group,while in the ZSP group,9(45.0%)patients returned to normal blood glucose and 1(5.0%)patient turned into DM.[Conclusions]ZSP effectively improved glucose control,increased the conversion of IGT to normal glucose,and improved the insulin resistance in elderly patients with IGT.This Chinese patent drug may have a clinical value for IGT. 展开更多
关键词 Zishen Pills Elderly patient Impaired glucose tolerance(IGT)
下载PDF
Rare-earth mediated dihydrogen activation and catalytic hydrogenation 被引量:1
3
作者 Yiwen Guan erli lu Xin Xu 《Journal of Rare Earths》 SCIE EI CAS CSCD 2021年第9期1017-1023,共7页
This review covers H-H bond cleavage of dihydrogen(H2)mediated by structurally well-defined rareearth metal(scandium,yttrium and lanthanides)complexes,and their applications in homogenous catalysis,such as catalytic h... This review covers H-H bond cleavage of dihydrogen(H2)mediated by structurally well-defined rareearth metal(scandium,yttrium and lanthanides)complexes,and their applications in homogenous catalysis,such as catalytic hydrogenation of unsaturated organic molecules.Depending on the mechanism of the H-H bond cleavage,this review is organized in two parts:(1)σ-bond metathesis,and(2)non-σ-metathesis H2 activation.The latter is a new trend in this research field and is the emphasis of this review.Converting H2 into inorganic rare-earth polyhydride complexes,albeit their potential applications as hydrogen-storage materiel,is not in the scope of this review. 展开更多
关键词 Rare earths Dihydrogen activation HYDROGENATION Homogeneous catalysis Cooperative effect
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部